The marked improvements in hepatic steatosis were associated with the decreases in plasma glucose and insulin levels, which is a reflection of ameliorated hepatic insulin sensitivity [40], as evidenced by a reduced AUC for the IPGTT. This evidence concerns the gene INS and fatty liver disease.